Volume 2 • Issue 3 • 1000107 (HB-8065, American Type Culture Collection, and Manassas, Virginia) and cultured according to the manufacturer's instructions. Tumor cells were seeded in 6 well dishes, before incubation in standard DMEM media with 10% fetal bovine serum, and a range of glucose, or fructose concentrations for a total of 72 h with fresh media supplied at 24 h intervals.
Introduction
Although clinical evidence indicates that there are significant differences in how glucose and fructose affect host metabolism [1] , the cellular mechanisms addressing specific steps of intermediary metabolism in liver cells have not yet been elucidated [2] . Recent developments in tracer substrate based metabolomics demonstrate that the [1,2-13 C 2 ]-D-glucose tracer offers precise in vitro characterization of pentose cycle, glycolysis and TCA cycle flux [3] , as well as analysis of de novo (new) fatty acid synthesis, turnover and modifications (via chain shortening or elongation) in cell pellets, plasma or tissues [4] . Processed nutritional products account for 80% of human refined carbohydrate intake. As the disaccharide sucrose (50% glucose, and 50% fructose) and high fructose corn syrup (HFCS, 45% glucose, and 55% fructose) are the main dietary sugars, we designed a tracer substrate-based metabolic study to characterize and compare product synthesis and related intermediary and/ or adaptive events in hepatoma cells following addition of 5 mM glucose or fructose to a base line (5 mM) glucose supply in the culture media.
Our findings indicate that hepatoma cells readily utilize fructose with significant differences in intermediary metabolism and product synthesis compared to glucose, even when fructose is provided at equivalent rates to glucose [5] . Fructose is also a potent inducer of transketolase flux via the non-oxidative pentose phosphate pathway to generate nucleic acid ribose as we have previously described [6] . Additionally, fructose enters the TCA cycle and of most significance, unlike glucose, it promotes new palmitate and oleate synthesis and their co-release into the culture media. twice in PBS, after which cell pellets were harvested using 5% Trypsin solution. Specific extractions were performed as described below and mass spectral data then obtained on a HP5975N mass selective detector connected to an HP6890N gas chromatograph. An Agilent J&W HP-5MS (30 m x 0.25 mM x 0.25 µm; part #: 19091S-433) analytical column was used for glucose, ribose, glutamate, and lactate analyses. For fatty acids and CO 2 analysis an Agilent J&W Scientific DB-23 (60 m x 0.25 mM x 0.15 µm; part #: 122-2361) column was used. Helium (>99.99% purity) was used as the carrier gas in the electron impact ionization (EI) mode or methane (>99.99% purity, Praxair, Los Angeles, CA) in the chemical ionization (CI) mode were used, respectively. Sample injections were performed using 100 split ratios directly into the heated (250 o C) and pressurized inlet interfaces. Lactate was extracted from cell culture media (0.2 ml) by ethylene chloride after acidification with HCL, derivatized to its propylamine-heptafluorobutyrate ester form and applied to the column. The m/z 328 (carbons 1-3 of lactate) (chemical ionization, CI) were monitored for the detection of m 1 (recycled lactate through the PC), m 2 (lactate produced by the Embden-Meyerhof-Parnas pathway) m 3 (lactate produced by triose cycling) for the estimation of pentose cycle activity [7] . For analysis of fatty acid synthesis, palmitate, and oleate were extracted after saponification of cell pellets in 30% KOH and 100% ethanol using petroleum ether. Fatty acids were then converted to their methylated derivative using 0.5 N methanolic-HCL, and palmitate and oleate were monitored at m/z 270, and m/z 264, respectively, for enrichment of glucose derived 13 C labeled acetyl units to reflect synthesis, elongation and desaturation of the new lipid fraction as determined by mass isotopomer distribution analysis (MIDA) [7, 8] . To characterize the pentose cycle's operation for nucleic acid ribose synthesis, RNA ribose was isolated by acid hydrolysis of cellular RNA after Trizol purification of cell extracts. Ribose was then derivatized to its aldonitrile acetate form using hydroxylamine in pyridine with acetic anhydride (Supelco, Bellefonte, PA) before mass spectral analyses. The ion cluster was monitored around the m/z 217 (carbons 3-5 of ribose) and m/z 242 (carbons 1-4 of ribose) (electron impact ionization, EI) to determine molar enrichment and the positional distribution of 13 C in ribose. Ribose molecules labeled with a single 13 C atom on the first carbon position (m/z 242 C 1 -C 4 fragment; M +1 ) recovered from RNA were used to gauge the ribose fraction produced by direct oxidation of glucose or fructose through the G6PDH pathway [5, 9] . Ribose molecules labeled with 13 C on the first two carbon positions (m/z 242 C 1 -C 4 fragment; M +2 ) were used to measure the fraction produced by transketolase [10] . Doubly labeled ribose molecules (m/z 217 C 3 -C 5 fragment; M +2 ) on the fourth and fifth carbon positions were used to measure molar fraction produced by triose recycling via triose phosphate isomerase and transketolase for nucleotide synthesis.
Complete glucose oxidation to 13 CO 2 analyses were performed from 100 µL media sample in a GC vial by added 50 µL of 0.1 M NaHCO 3 . Then 50 µL of 1M HCL was added. The vials were immediately capped and placed on the GC/MS sample tray for analysis at the m/z 44 and m/z 45 ion groups [11] . Glutamate was extracted from 100 µL media using 100 µL of ultrapure water and 100 µL of HPLC grade acetone. The mixture was frozen at -80 ο C for one hour, vortexed for 60 seconds and centrifuged at 13000 rpm for 30 minutes. The supernatant was transferred into a 13 inche glass test tube on ice and dried under nitrogen. Glutamate was converted to its N-trifluoroacetyl-n-butyl derivative by adding 200 µL 3.0 M HCL in n-Butanol (Regis Chemical. Company, Chicago, IL) and incubating the mixture at 100 ο C for 1 hour. Samples were then treated with 100 µL dichloromethane and 25 µL trifluoroacetic anhydride (Sigma-Aldrich) at room temperature for 20 minutes and dried under nitrogen. The residue was transferred into GC vials in 200 µL dichloromethane. Under EI conditions, ionization of TAB-glutamate produces two fragments, m/z 198 and m/z 152, corresponding to the C 2 -C 5 and C 2 -C 4 fragments of glutamate [12] . Of the m/z 198 fragment, M +2 13 C glutamate on the C 4 -C 5 carbon positions reflects pyruvate dehydrogenase activity and hence oxidative phosphorylation (catabolic use of glucose) while M +1 13 C glutamate reflects lactate and pyruvate cycling and turnover.
Quantitative metabolite analysis
Media and cell pellet metabolic products were quantitated and compared by integrated peak area values under corresponding total ion current (TIC) ID logs as determined by retention times in the selected ion monitoring mode measured by blinded spectra processing personnel (see acknowledgments). Average peak width values were less than 5 seconds (ChemStation Integrator, Agilent, and Palo Alto, CA) using identical injection volume, solvent strength and split ratios with that of natural 13 C labeled external chromatographic standards. Concentration dependent integrated chromatographic TIC areas are displayed as arbitrary values of metabolite concentration among the control-, glucose-and fructose-treated groups [4, 6] .
Statistical analysis
Data are presented as arithmetic mean (average) plus standard deviation (x + SD) of three independent observations using three independent integration results with background subtraction of the natural labeled 13 C standard and its derivatizing agent. Two-tailed independent sample "t"-test (Student's t-test) was used and probability values of less than 0.05 with 95% confidence intervals were considered to indicate true differences in metabolite flux results after the added glucose and fructose treatments of HepG2 cells.
Results

HepG2 cells oxidize glucose at lower rates in the presence of fructose
To compare glucose and fructose derived acetate oxidation in the TCA cycle in excess of other substrates we determined the ratio of 12 CO 2 's replacement with 13 CO 2 in the culture media following the addition of 5 mM glucose or fructose to a 4.5 mM baseline glucose containing 10% [1,2-13 C 2 ]-D-glucose tracer (0.5 mM). This enabled us to analyze continuous substrate and product labeling for 72 hours in the HepG2 cell cultures. As depicted in Figure 1A , 13 CO 2 delta values were similar in culture media derived from 5 mM glucose-(5.78 (SD=0.11)) and 10 mM glucose-(5.95 (SD=0.65)) treated cells indicating that addition of 5 mM glucose did not affect the ratio of complete glucosederived acetate oxidation to that of 12 C labeled substrates. In contrast, addition of 5 mM fructose significantly decreased 13 CO 2 Delta to 4.61 (SD=0.37) by its contribution to TCA cycle citrate as the unlabeled acetate/oxaloacetate source ( Figure 1A ). Carbon dioxide production was maintained in the presence of fructose based on the >10 X10 6 CO 2 chromatographic abundance (not shown).
Fructose enters the TCA cycle and decreases glutamate output while maintaining pyruvate dehydrogenase and pyruvate carboxylase flux ratios for pyruvate's entry into the cycle in HepG2 cells
Media glutamate, which is synthesized via citrate, isocitrate and ketoglutarate (α), completely equilibrated with tracer glucose after 72 hours culture as demonstrated by the 13 Figure 1B ). However, when 5 mM fructose was added to the 5 mM control glucose concentration, the 13 C labeled media glutamate fraction was reduced to 8.4 (SD=0.46) ( Figure 1B ). Examination of the positions of 13 C labeling in media glutamate revealed that positional 13 C labeling was very similar at both the M+1 (one 13 C substitution, m/z 198 (C 2 -C 5 ) fragment, reflecting lactate and pyruvate cycling and turnover) and M+2 (two 13 C substitutions, m/z 198 (C 2 -C 5 ) fragment, reflecting pyruvate dehydrogenase activity and hence oxidative phosphorylation) positions among the groups (5 mM glucose control: M+1, 56.57% (SD=2.81); M+2, 38.36% (SD=1.51); 5 mM added glucose: M+1, 52.12% (SD=3.62); M+2, 42.23% (SD=2.36) and 5 mM added fructose: M+1, 53.12% (SD=1.84); M+2 39.99% (SD=1.09)), respectively ( Figure  1C and 1D). Glutamate concentrations, measured by the integrated peak area of the parent m/z 198 ion peak were 616467 (SD=40623) arbitrary units (AU) in control-, 609141 (SD=18586) AU in 5 mM added glucose-and 527595 (SD=33211) AU in added fructose-treated HepG2 cells ( Figure 1E ). These results indicate a significant decrease in glutamate synthesis and release from HepG2 cells after fructose treatment in comparison with the 5 mM glucose control and 10 mM glucose-treated cells (p < 0.01).
Fructose maintains high oxidative pentose cycle flux, decreases lactate 13 C labeling from glucose and impairs lactate efflux from HepG2 cells
Media lactate synthesized directly from glucose via glycolysis with M+2 13 C and indirectly from pentose via the oxidative branch of the pentose cycle (PPC) followed by recycling into glycolysis by transketolase and transaldolase with M+1 13 C (see below) partially equilibrated with tracer glucose after 72 hours culture (Control, 3.34% (SD=0.71)). Increasing glucose concentrations by two-fold to 10 mM resulted in a ~1.5 fold increase in released 13 C labeled lactate (5.47% (SD-0.62) ( Figure 2A ). In contrast, addition of 5 mM fructose reduced the 13 C labeled lactate fraction to 2.96% (SD=0.69) ( Figure  2A ). Examination of the 13 C labeled media lactic acid fractions' demonstrated that positional 13 C labeling of lactate at the M +1 position (one 13 C substitution, m/z 328 (C 1 -C 3 ), reflecting recycled lactate through the pentose cycle) 28.67% (SD=5.30) and M+2 position (two 13 C substitutions, m/z 328 (C 1 -C 3 ) reflecting lactate produced by the Embden-Myerhof-Parnas pathway) 65.49% (SD=4.92) was similar in controls and not significantly altered by addition of 5 mM glucose (M +1 , 48.13% (SD=3.44); M +2, 47.67% (SD=3.13)) or fructose (M +1 , 48.42% (SD=3.32); M +2, 47.44% (SD=3.01)) ( Figure 2B and 2C). Pentose cycle (G6PDH) flux relative to glycolysis, also known as the "NADPH yielding direct glucose oxidizing pentose cycle reaction" was similarly increased to 25.23% (SD=2.55) and 25.12% (SD=2.64) in both glucoseand fructose-treated cells compared to control (13.48% (SD=2.99)). This indicates that the number of glucose molecules entering direct oxidation doubled following glucose-and fructose-treatment. As each glucose molecules yields two reduced NADP molecules via direct oxidation of its first carbon, this generates NADPH in quadruple molar quantities, which serves as the reducing equivalent for fatty acid synthesis ( Figure 2D ). Triose futile cycling was relatively low in all treatments as indicated by the less than 5% M +3 13 C lactate fraction ( Figure 2E ). Lactate concentrations, measured by the integrated peak area of the parent m/z 328 ion peak increased significantly following glucose-treatment (593279 (SD=118124)) compared to control-(217388 (SD=51477)) and fructose-treated cells (363956 (SD=68570)), respectively ( Figure 1F ), in keeping increased lactate synthesis and release from glucose-treated HepG2 cells.
Fructose contributes directly to nucleotide ribose synthesis and recycles glucose-derived glyceraldehyde-3P via transketolase in HepG2 cells
Cell pellet ribose is the backbone pentose sugar of nucleotide synthesis and is produced either directly from glucose via the oxidative branch of the pentose cycle with M+1 13 C or indirectly from fructose by transketolase with M+2 13 C (sees below). Direct and indirect ribose synthesis partially equilibrated with tracer glucose after 72 hours culture as shown by the 4.69% (SD=0.14) and 5.73% (SD=0.62) 13 C labeled C 1 -C 4 (top, m/z 242) fractions in the 5 mM control and 10 mM glucose treated HepG2 culture media, respectively ( Figure 3A) . In contrast, addition of 5 mM fructose to the 5 mM control glucose-treated cells reduced the 13 C labeled ribose fraction to 4.07% (SD=0.11) ( Figure  3A) , indicating that the unlabeled fructose directly contributes to RNA ribose synthesis after phosphorylation as the C 2 (β) keto-group-donor. Examination of positional 13 C labeling of the 13 C labeled pellet ribose C 1 -C 4 (top, m/z 242) fractions demonstrated that 89.54% (SD=1.65) of control-, 79.33% (SD=3.93) of 10 mM glucose and 79.61% (SD=0.10) of fructose-treated cells had one 13 C substitution (M +1 , one 13 C substitution, m/z 242 (C 1 -C 4 ) reflecting the ribose fraction produced by direct oxidation of glucose or fructose through the G6PDH) and 9.31% (SD=0.81) control, 14.83% (SD=1.19) 10 mM glucose and 15.45% (SD=1.85) added fructose had two 13 C substitutions, (M+2, m/z 242 (C 1 -C 4 ) pathway reflecting the fraction produced by transketolase) respectively ( Figure 3B and 3C). Triose (glyceraldehyde-3P) recycling into ribose via transketolase increased to 76.47% (SD=0.64) after glucose-and 79.83% (SD=1.26) following fructose-treatment, respectively, compared to 71.27% (SD=1.78) in control glucose pellets ( Figure 3D ). Integrated peak area of the m/z 242 ion peak was similar following control-(5135 (SD=1541)), glucose-(4265 (SD=195)) and fructose-(4676 (SD=1246)) treatment (not shown).
Fructose supplies acetyl-CoA for new palmitate and oleate synthesis while strongly promoting fatty acid co-release from HepG2 cells
Palmitate (C16:0) and oleate (C18:1) are abundant long chain fatty acids of triglycerides assembled by liver cells for transport. Palmitate readily incorporated the tracer glucose after 72 hours culture as shown by the chromatographic analyses of the pellets. Palmitate 13 C molar enrichment was 0.18 (SD=0.02) in control and 0.26 (SD=0.01) in 10 mM glucose-treated HepG2 cells. Addition of 5 mM fructose reduced the 13 C content in palmitate to 0.21 (SD=0.01) relative to that of added glucose ( Figure 4A ), which indicates that unlabeled fructose-derived acetyl-CoA directly contributes to palmitate synthesis (see also below) in HepG2 cells. Interestingly, intracellular oleate also incorporated the glucose tracer more avidly as demonstrated by the 0.36 (SD=0.02) and 13 C molar oleate enrichment in the control-and 10 mM glucose-treated HepG2 cells, respectively. Similar to palmitate 13 C enrichment, addition of 5 mM fructose reduced 13 C content in oleate to 0.36 (SD=0.01) compared to 10 mM glucose ( Figure 4B ). Release of palmitate into the culture media after 72 hours culture was similar in control (0.17 (SD=0.01) and 10 mM glucose groups (0.18 (SD=0.007)). In contrast, addition of 5 mM fructose markedly reduced the 13 C content in released palmitate to 0.10 (SD=0.01) ( Figure 4C ), which indicates that unlabeled fructose-derived acetyl-CoA significantly contributes to released palmitate synthesis in HepG2 cells. Released oleate also incorporated tracer glucose with higher intensity, showing 0.29% (SD=0.01) and 0.32 (SD=0.02) 13 C molar enrichment in released oleate in the 5 mM control and 10 mM glucose treated HepG2 cells, respectively. However, addition of 5 mM fructose resulted in reduced 13 C oleate content (0.26 (SD=0.02)) relative to 10 mM glucose-treated cells ( Figure 4D ). Intracellular fatty acid M+2 positional 13 C palmitate and oleate labeling, the latter requiring pyruvate dehydrogenase activity followed by i mMediate citrate shuttling were similar in all treatment groups (M+2 positional 13 C palmitate: control; 63.71% (SD=0.64), 10 mM glucose; 65.80% (SD=0.47) and 5 mM fructose; 64.09% (SD=0.72) and (M+2 positional 13 C oleate: control; 29.77% (SD=1.28), 10 mM glucose; 35.87% (SD=0.44) and 5 mM fructose; 32.28% (SD=0.54)) (not shown). Analysis of released 13 C labeled fatty acid fractions demonstrated increased M+2 positional 13 C palmitate labeling in 10 mM glucose-treated (52.08% (SD=0.64)) compared to control-(49.59% (SD=0.32)) and 5 mM fructose-treated (48.85% (SD=2.8)) cells (not shown) but similar M+2 positional 13 C oleate labeling in all three groups (Control; 20.88% (SD=2.17); 10 mM glucose (22.78% (SD=2.73)) and 5 mM fructose; 16.34% (SD=1.78)) (not shown).
Our analysis also revealed that intracellular palmitate and oleate content (integrated peak area) increased following 10 mM glucose (Palmitate: 25394 (SD=1485; Oleate: 12124 (SD=1192) in comparison to control (Palmitate: 20515 (SD=1735; Oleate: 11012 (SD=1655). In contrast, 5 mM fructose-treatment led to a marked reduction in intracellular palmitate and oleate levels (Palmitate: 12684 (SD=586); Oleate: 6456 (SD=576) ( Figure 4E and 4F) . In marked contrast to intracellular palmitate and oleate levels, released palmitate and oleate contents (integrated peak areas) were significantly increased after fructose treatment ( Figure 4G and 4H) (Palmitate: 4613 (SD=580); Oleate: 3954 (SD=708) in comparison to 10 mM glucose-(Palmitate: 2009 (SD=80); Oleate: 949 (SD=77) and control-(Palmitate: 2340 (SD=347); Oleate: 1068 (SD=307) treated HepG2 cells. Furthermore, intracellular palmitate production by de novo synthesis via citrate formation, its shuttling and fatty acid synthase (FAS) ( Figure 4I ) were also increased in glucose-63.09% (SD=0.32) and fructose-56.12% (SD=3.40) treated cells compared to control (44.6% (SD=2.36)). There was also a significant decrease in glucose-derived acetyl-CoA contribution to palmitate in fructose-(1.60% (SD=0.1) compared to control-(18.2% (SD=0.5)) and 10 mM glucose-(18.8% (SD=0.5)) treated cells, quantitated as the fraction of total acetyl-CoA from all sources ( Figure 4J ).
Discussion
The human hepatocellular carcinoma HepG2 cell was selected for our studies based on similarities with isolated human hepatocytes. These features include their ability to 1) metabolize fructose to two carbon organic acids [13] , 2) maintain most primary liver cell functions including ureagenesis, glucuronidation, sulfation and oxidation [14] , 3) respond to food pro-mutagens in a similar manner to human liver cells [15] and 4) exhibit nicotinic acid and nicotinamide transport (cofactors for oxidative decarboxylation and direct glucose oxidation) which is unaffected by related organic anions such as lactate, acetate, butyrate, succinate or citrate availability and influx [16] .
Recent studies have reported mean circulating serum fructose concentrations around 1.9+/-0.4 mM in unprocessed serum samples from fasting healthy volunteers [17] or 0.046+/-0.025 mM after separation of hemoglobin from plasma [18] . Using enzymatic and chromatographic assays, we demonstrated that plasma fructose levels rose rapidly to 16.3+/-1.2 mM 15 minutes after ingestion of a fructose and glucose-containing beverage. We therefore chose to examine combination treatment with glucose and fructose concentrations equivalent to ~ 10 mM total carbohydrate as we believe this concentration is reflective of portal sugar concentrations following ingestion of high refined carbohydrate quantities easily attained from western diets.
Although it is known that short-term fructose administration increases circulating VLDL triacylglycerols by about 58% in human subjects [19] , the exact mechanisms involved remain speculative [2] . Based on this study it is evident that fructose maintains a high glucose direct oxidation rate via the oxidative branch of the pentose cycle, very similar to that of added glucose, while fructose itself does not undergo effective direct oxidation. On the other hand fructose profoundly alters intermediary metabolism and impairs the metabolism of glucose in a competitive manner in a similar way to that seen in the Randle cycle [20, 21] . As the Randle cycle highlights competition between glucose and fatty acids for their oxidation in muscle and adipose tissue [22] , our study, for the first time, demonstrates the same effect of fructose in hepatic cells. Our study demonstrates fructose-mediated impaired glucose oxidative decarboxylation as evidenced by our observed reduction in both 13CO 2 and glutamate while maintaining overall CO 2 production following fructose-treatment. The results reveal a new dimension of metabolic control whereby the nutrient, fructose, modifies hepatic metabolism of another sugar in a similar way to fatty acids. Although it has been shown that the utilization of one nutrient (fatty acid) inhibits the use of the other (glucose) directly in isolated heart and skeletal muscle preparations [21] , our report is the first we are aware of that demonstrates the same interaction between two dietary sugars. The glucose-fructose cycle is thus a novel biochemical phenomenon that is determined by fructose availability and controls fuel selection and product disposal via adaptation to refined sugar supply and demand in cells. It is likely that other factors such as hormones that act to control circulating substrate concentrations play a role in the interplay between glucose and fructose and this will require clarification in additional in vivo studies.
Our glucose tracer studies indicate that the manner by which fructose impairs glucose metabolism does not include the proposed mechanisms whereby high concentrations of fatty acids inhibit glucose utilization, including inhibition of glucose transport and/ or phosphorylation or reduced activity of pyruvate dehydrogenase (PDH) [20] . This is supported by the similar positional 13 C labeling in glutamate in the control and fructose-treated groups and the identical positional 13 C labeling in lactate following 10 mM glucose-and fructose-treatments in our study. This finding indicates that glucose and fat and glucose and fructose may interact via distinct mechanisms.
The mechanisms by which fructose alters glucose metabolism in HepG2 cells are consistent with three unexpected results. Firstly, fructose resulted in a striking, 2-3-fold increase in palmitate and oleate co-release, which is typical and necessary in liver cells for effective triglyceride assembly and transport, as palmitate and oleate are transported together in VLDL. Secondly, the synthesis pathways of released palmitate and oleate are very different from intracellular palmitate and oleate synthesis. In particular, released fatty acids contained less M +2 derived from glucose and this is a very specific marker of increased glucose decarboxylation via the oxidative and direct pathways and the subsequent channeling of acetyl-CoA product to the fatty acid synthase complex. The exact reason for our observed difference in intracellular versus secreted oleate labeling is unclear but we speculate may involve different metabolite compartmentalization. Thirdly, hepatoma cells retain less palmitate and oleate after fructose treatment, which indicates that fatty acid accumulation in fructoseinduced steatosis may exclude palmitate and oleate accumulation.
In conclusion, it is evident that fructose impairs hepatic HepG2 cell glucose metabolism as profoundly as that observed with fatty acid administration in the Randle cycle. Our study puts in perspective the finding that although a high combination fructose and fatty acid diet had additive effects on intrahepatocellular lipid deposition, the diet exhibited neutralizing effects on VLDL triglyceride release [19] . Our study also demonstrates that although fructose stimulates hepatic VLDL triacylglycerol secretion it also depletes two important selective fatty acid pools, namely that of palmitate and oleate, whereby dietderived long chain saturated fatty acids may be stored. These diverse, yet interfering mechanisms will shed further light on the complexities involved in hidden disease phenotypes and may have relevance for population scale obesity. Additionally, we anticipate that they will trigger additional tracer substrate guided investigations in the field to better understand the mechanisms by which dietary nutrients interact to mediate human disease.
